Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • shiloh pl
    Junior Member
    • Jun 2021
    • 2

    #1

    Methylation and enhancer question

    Hi, thank you for viewing this question. I have a background in biology but not a background in bioinformatics. My question relates to conservation of the positions of enhancers.

    I am looking at the supplementary material of a study that says there are methylations at location 90752569 of chromosome 10, defined as a S_Shore (UCSC_CpG_Islands_Name=chr10:90750293-90751108) of the FAS gene (they mention its the FAS gene according to UCSC_RefGene_Name.) Under the column Enhancer it says "NA".

    However, on Genecard this location is not the location of FAS. Genecard states location of FAS is "chr10:88948601-88954174 (GRCh38/hg38)chr10:90708358-90713931 (GRCh37/hg19))"

    Location 90752569 on chromosome 10 does not seem to fit with FAS but it does with ACTA2 according to Genecard. Genomic Location of ACTA2: chr10:88988929-88997555 (GRCh38/hg38)chr10:90748686-90757312 (GRCh37/hg19)

    What is the meaning of this? Is this a methylation of FAS or ACTA2? Is this an enhancer region? Genecard says FAS has an enhancer for ACTA2. (https://www.genecards.org/cgi-bin/ca....pl?gene=ACTA2) I am grateful for an explanation of this.
    Last edited by shiloh pl; 06-30-2021, 11:32 PM. Reason: duplication

Latest Articles

Collapse

  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM
  • SEQadmin2
    New Genomics Technologies Take Aim at Long-Standing Limits
    by SEQadmin2


    Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

    We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
    ...
    09-28-2026, 10:25 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 10-15-2026, 10:52 AM
0 responses
12 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-14-2026, 05:39 AM
0 responses
20 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-13-2026, 09:56 AM
0 responses
19 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-09-2026, 11:14 AM
0 responses
27 views
0 reactions
Last Post SEQadmin2  
Working...